SCHEMBL22010909

SCHEMBL22010909

Brc1ccc(Oc2cncs2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.41
PTGS1 P23219 2/20 0.41
PTGS2 P35354 2/20 0.41
MAPT P10636 1/20 0.41
HDAC8 Q9BY41 1/20 0.40
ICAM1 P05362 2/20 0.35
SELE P16581 2/20 0.35
CDC7 O00311 1/20 0.35
DYRK3 O43781 1/20 0.35
ROCK2 O75116 1/20 0.35
MAP4K4 O95819 1/20 0.35
FYN P06241 1/20 0.35
CDK1 P06493 1/20 0.35
PIM1 P11309 1/20 0.35
PRKACA P17612 1/20 0.35
VCAM1 P19320 1/20 0.35
CDK2 P24941 1/20 0.35
FLT4 P35916 1/20 0.35
MAPK9 P45984 1/20 0.35
CSNK1A1 P48729 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25370601 0.77 HDAC8 (0.31) HDAC8GAA
SCHEMBL3999904 0.75 MAPK1 (0.55) PTGS1PTGS2MAPTHDAC8SLC6A3
SCHEMBL25370600 0.71 MAPT (0.42) LTA4HPTGS1PTGS2MAPTICAM1
SCHEMBL4004418 0.69 ALDH1A1 (0.38) MAPTHDAC8GAAMAPK1TDP1
SCHEMBL3842527 0.68 MAPT (0.74) LTA4HPTGS2MAPTSLC6A3SLC6A2
SCHEMBL391385 0.68 MAPT (0.74) LTA4HPTGS2MAPTSLC6A3SLC6A2
SCHEMBL3843978 0.68 MAPT (0.74) LTA4HPTGS2MAPTSLC6A3SLC6A2
SCHEMBL8130697 0.68 MAPT (0.43) LTA4HMAPTSLC6A3SLC6A2SLC6A4
SCHEMBL4003143 0.68 HDAC8 (0.35) HDAC8ALDH1A1
SCHEMBL999315 0.67 HDAC8 (0.46) MAPTHDAC8DYRK1ASLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 US disclosed
CN-119730846-A Kinase modulators and methods of use thereof 神经元23公司 2025-03-28 CN disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 WO disclosed
CN-113272302-B Antibiotic compound, method for producing same, pharmaceutical composition containing same, and use thereof 德彪药业国际股份公司 2024-08-13 CN disclosed
US-20240025906-A1 KINASE MODULATORS AND METHODS OF USE THEREOF SUNDANCE BIOSCIENCES, INC. 2024-01-25 US disclosed
US-20240025906-A1 KINASE MODULATORS AND METHODS OF USE THEREOF SUNDANCE BIOSCIENCES, INC. 2024-01-25 US disclosed
CN-113272302-A Antibiotic compounds, process for their manufacture, pharmaceutical compositions containing them and their use 德彪药业国际股份公司 2021-08-17 CN disclosed
WO-2020099341-A1 ANTIBIOTIC COMPOUNDS, METHODS OF MANUFACTURING THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF DEBIOPHARM INTERNATIONAL S.A. (CH) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS LTA4H 4163/4885PTGS1 2145/4885PTGS2 2385/4885
US-20240025906-A1 KINASE MODULATORS AND METHODS OF USE THEREOF TYK2, JAK1, JAK3 LTA4H 2979/4885PTGS1 1754/4885PTGS2 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.